Previous Close | 22.04 |
Open | 22.99 |
Bid | 22.88 x 200 |
Ask | 22.95 x 400 |
Day's Range | 22.74 - 23.70 |
52 Week Range | 19.65 - 79.38 |
Volume | |
Avg. Volume | 608,763 |
Market Cap | 1.232B |
Beta (5Y Monthly) | 0.24 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.76 |
Earnings Date | May 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 66.77 |
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.